QuidelOrtho Corporation QDEL EU medical device regulation transition costs
EU medical device regulation transition costs at other companies
Other financials
Where this comes from
Reported directly by QuidelOrtho Corporation in its filing.
Tagged under the XBRL concept qdel:EUMedicalDeviceRegulationTransitionCosts.
The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about QuidelOrtho Corporation's eu medical device regulation transition costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is QuidelOrtho Corporation's EU medical device regulation transition costs?
- QuidelOrtho Corporation (QDEL) reported EU medical device regulation transition costs of $700K in Q1 2026.
- How has QuidelOrtho Corporation's EU medical device regulation transition costs changed year-over-year?
- QuidelOrtho Corporation's EU medical device regulation transition costs increased by 250.0% year-over-year, from $200K to $700K.
- What is the long-term trend for QuidelOrtho Corporation's EU medical device regulation transition costs?
- Over 2 years (2023 to 2025), QuidelOrtho Corporation's EU medical device regulation transition costs has grown at a -47.1% compound annual growth rate (CAGR), from $2.5M to $700K.
- What does EU medical device regulation transition costs mean?
- Specific costs incurred to comply with updated regulatory requirements for medical devices within the European Union. This highlights the impact of regulatory changes on operational expenses and the cost of maintaining market access.